Log In
Print
BCIQ
Print
Print this Print this
 

Avalide, irbesartan/hydrochlorothiazide (CoAprovel)

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionCombination of the angiotensin II receptor antagonist Avapro irbesartan and the diuretic hydrochlorothiazide
Molecular Target Angiotensin II type 1 (AT1) receptor (AGTR1)
Mechanism of ActionAngiotensin II type 1 (AT1) receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat hypertension
Regulatory Designation

Partner

Sanofi; Shionogi & Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today